Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT05440942 · COMPLETED
Trial details
- NCT number
- NCT05440942
- Sponsor
- Peter Hosein, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-19
- Primary completion
- 2025-05-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.